ÂÜÀòÂÒÂ×

Dr. Zhao-Wilson has more than 15 years of experience as a senior executive of start-up, early-stage, and established companies in the biotech industry. She was a corporate development executive at Aviron, a biopharmaceutical company that recently merged with MedImmune. She was the founder and CEO of InCell, a biomedical company. Dr. Zhao-Wilson served as a board director and senior executive officer at Baekon, a biotech company.

Dr. Zhao-Wilson is a Professor at the Chinese Academy of Preventative Medicine in Beijing. As a Research Scientist at Stanford Medical Center, she conducted research focused on gene regulation in various cancers that are related to steroid hormone receptors. Dr. Zhao-Wilson received her M.S. in molecular genetics and Cell Biology from the Institute of Cell Biology, Chinese Academy of Sciences, and her Ph.D. in Cellular and Developmental Biology from The Ohio State University. Her MBA, from Fisher School of Business, MIIS focused on international business management.

Dr. Zhao-Wilson has been awarded four U.S. patents and has published numerous research articles and book chapters. She has successfully obtained research funding through an SBIR Grant from the U.S. Department of Health and Human Services and an award from the Katharine McCormick Fund. She has also lectured extensively at international research institutions including the U.S. National Institutes of Health, the Max-Planck Institute in Germany, and at numerous universities in the U.S., China, and European countries.